Pramodini Medicare Limited, founded in 2000, is one of the leading diagnostic services providers in India across radiology, clinical laboratory, and nuclear medicine segments. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.
Market Dashboard
Pramodini Medicare
ListedSMEBook Building Issue
Issue Price
₹110 to ₹118Face Value
₹10 Per Equity ShareIssue Size
₹69.04 Cr.Listing On
NSE SME
Live
Allotment Available
Check your individual allotment on the official registrar portal.
Grey Market
₹0
+0.00% Est. Listing Premium
Est. Listing Price₹118
Updated: Not available
About Pramodini Medicare IPO
Financial Health
Live Subscriptions
Updated: 14 Aug 2026, 13:27Tracking
Frequently Asked Questions
The public subscription window officially opens on 12 August 2026 and concludes at 5:00 PM IST on 14 August 2026.
As of the latest market information, the GMP is ₹0, indicating a 0.00% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹110 to ₹118. Retail investors must bid for at least 2,400 shares, requiring a block investment of ₹2,83,200.
The allotment has been detected as available in the Purva Sharegistry (India) Pvt. Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 19 August 2026.
The registrar for this IPO is Purva Sharegistry (India) Pvt. Ltd..
The issue size for Pramodini Medicare is ₹69.04 Cr..
The current status of the Pramodini Medicare IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.